A comprehensive view of Illnesses / Symptoms / Conditions. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Emergency contraception-related ER visits in the US fell 96% between 2006 and 2020, associated with decrease in hospital expenses from US$7.6M to US$385,946; study links trend with 2006 approval of over-the-counter emergency contraception

Regeneron announces European Medicines Agency has accepted for review the Marketing Authorization Application for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma

New York A.G. James secures US$150M multistate settlement in principle with Hikma Pharmaceuticals to help combat opioid crisis; settlement includes US$115M in cash and US$35Min opioid addiction treatment medication

AstraZeneca announces positive high-level results from Japan Phase 3 trial of acoramidis in adults with transthyretin-mediated amyloid cardiomyopathy; data will be submitted to Japan's health authority for regulatory review

US Dept. of Health announces funding opportunities for two grant programs aimed at expanding substance use disorder treatment for pregnant and postpartum women; grant opportunities total US$28M

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count